Conclusions: Antihypertensive therapy in pregnancy with Labetalol may have the potential to impair fetal behavior in low degrees hypertensivediseasesofpregnancy.
1
However, long-term data are lacking among women with gestationalhypertension without proteinuria.
2
Maternal adverse pregnancy outcomes were pre-eclampsia, gestational diabetes, and gestationalhypertension.
3
We ascertained gestationalhypertension, pre-eclampsia, gestational diabetes and preterm birth diagnoses from medical records.
4
Patients: A total of 65 women with gestationalhypertension at 24-26 weeks.
5
When looking at gestationalhypertension and pre-eclampsia as outcomes, (multiple) logistic regression was used in the analysis.
1
Methods: Secondary analysis of a randomized multicenter trial of antioxidant supplementation versus placebo in nulliparous low-risk women to prevent pregnancyassociatedhypertension.
Ús de pregnancy-induced hypertension en anglès
1
The results were adjusted for maternal age, gestational age and pregnancy-inducedhypertension.
2
During her last pregnancy, Michelle was diagnosed with pre-eclampsia, or pregnancy-inducedhypertension.
3
Group 1 patients had a significantly higher incidence of pregnancy-inducedhypertension and preterm birth.
4
Of all the interaction terms, only the bromocriptine by pregnancy-inducedhypertension interaction was significant.
5
Incidence of pregnancy-inducedhypertension or preeclampsia, gestational week at delivery and birthweight were recorded.
6
No adverse effects were observed in women with pregnancy-inducedhypertension.
7
During her pregnancy with her last baby, Michelle was diagnosed with pre-eclampsia, or pregnancy-inducedhypertension.
8
Intrauterine growth retardation with or without pregnancy-inducedhypertension was observed more often in the ICSI group.
9
In the 4th case, the probable cause of death was intracranial hemorrhage caused by pregnancy-inducedhypertension.
10
Conclusions: Overt diabetes in pregnancy is significantly associated with maternal complications such as retinopathy and pregnancy-inducedhypertension.
11
In pregnancy-inducedhypertension this attenuation is reverted.
12
Avoiding the elective use of this drug in patients with pregnancy-inducedhypertension might constitute a reasonable clinical response to these findings.
13
These findings support the contention that patients with antepartum pregnancy-inducedhypertension who receive bromocriptine for lactation suppression are at increased risk for postpartum hypertension.
14
The panel concluded that there was a probable link with six illnesses: kidney and testicular cancer, ulcerative colitis, thyroid disease, pregnancy-inducedhypertension and high cholesterol.
15
Methods: 24-hour automatic blood pressure monitoring was performed at 8-16 and 20-25 gestational weeks in 104 women at risk of pregnancy-inducedhypertension or preeclampsia.
16
Pregnancy-inducedhypertension indicators, systolic blood pressure, 24 hours proteinuria, pup weight and maternal weight were measured.